NCT07627568 Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.
| NCT ID | NCT07627568 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Freiburg |
| Condition | Acute Myeloid Leukemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-05-30 |
| Primary Completion | 2027-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2026-05-30 with a primary completion date of 2027-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The white blood cells of patients with acute myeloid leukemia that have undergone allogeneic stem cell transplantation will be investigated. These are patient where the leukemia has returned after the transplantation.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of acute myeloid leukemia with NPM1 mutations or KMT2A rearrangements * Hematological relapse after allo-HCT * 18 years or older Exclusion Criteria: * no signed informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07627568 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Myeloid Leukemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07627568 currently recruiting?
Yes, NCT07627568 is actively recruiting participants. Contact the research team at robert.zeiser@uniklinik-freiburg.de for enrollment information.
Where is the NCT07627568 trial being conducted?
This trial is being conducted at Freiburg im Breisgau, Germany.
Who is sponsoring the NCT07627568 clinical trial?
NCT07627568 is sponsored by University of Freiburg. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.